Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from Streptomyces avermitilis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Compactin and pravastatin are competitive cholesterol biosynthesis inhibitors of 3-hydroxy-3- methylglutaryl-CoA reductase and belong to the statin drugs; however, the latter shows superior pharmacokinetic characteristics. Previously, we reported that the bacterial P450, CYP105D7, from Streptomyces avermitilis can catalyze the hydroxylation of 1-deoxypentalenic acid, diclofenac, and naringenin. Here, we demonstrate that CYP105D7 could also catalyze compactin hydroxylation in vitro. In the presence of both bacterial and cyanobacterial redox partner systems with an NADPH regeneration system, the reaction produced two hydroxylated products, including pravastatin (hydroxylated at the C6 position). The steadystate kinetic parameters were measured using the redox partners of putidaredoxin and its reductase. The Km and kcat values for compactin were 39.1 ± 8.8 μM and 1.12 ± 0.09 min-1, respectively. The kcat/Km value for compactin (0.029 min-1·μM-1) was lower than that for diclofenac (0.114 min-1·μM-1). Spectroscopic analysis showed that CYP105D7 binds to compactin with a Kd value of 17.5 ± 3.6 μM. Molecular docking analysis was performed to build a possible binding model of compactin. Comparisons of different substrates with CYP105D7 were conclusively illustrated for the first time.
Abstract
Compactin and pravastatin are competitive cholesterol biosynthesis inhibitors of 3-hydroxy-3- methylglutaryl-CoA reductase and belong to the statin drugs; however, the latter shows superior pharmacokinetic characteristics. Previously, we reported that the bacterial P450, CYP105D7, from Streptomyces avermitilis can catalyze the hydroxylation of 1-deoxypentalenic acid, diclofenac, and naringenin. Here, we demonstrate that CYP105D7 could also catalyze compactin hydroxylation in vitro. In the presence of both bacterial and cyanobacterial redox partner systems with an NADPH regeneration system, the reaction produced two hydroxylated products, including pravastatin (hydroxylated at the C6 position). The steadystate kinetic parameters were measured using the redox partners of putidaredoxin and its reductase. The Km and kcat values for compactin were 39.1 ± 8.8 μM and 1.12 ± 0.09 min-1, respectively. The kcat/Km value for compactin (0.029 min-1·μM-1) was lower than that for diclofenac (0.114 min-1·μM-1). Spectroscopic analysis showed that CYP105D7 binds to compactin with a Kd value of 17.5 ± 3.6 μM. Molecular docking analysis was performed to build a possible binding model of compactin. Comparisons of different substrates with CYP105D7 were conclusively illustrated for the first time.
참고문헌 (33)
- Xu LH, "Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state", J. Bacteriol, 191, pp.1211~1219 (2009)
- Makino T, "Regio- and stereospecific hydroxylation of various steroids at the 16α position of the D ring by the Streptomyces griseus cytochrome P450 CYP154C3", Appl. Environ. Microbiol, 80, pp.1371~1379 (2014)
- Podust LM, "Diversity of P450 enzymes in the biosynthesis of natural products", Nat. Prod. Rep, 29, pp.1251~1266 (2012)
- Bernhardt R., "Cytochromes P450 as versatile biocatalysts", J. Biotechnol, 124, pp.128~145 (2006)
- Ma L, "Reconstitution of the in vitro activity of the cyclosporinespecific P450 hydroxylase from Sebekia benihana and development of a heterologous whole-cell biotransformation system", Appl. Environ. Microbiol, 81, pp.6268~6275 (2015)
- Fasan R., "Tuning P450 enzymes as oxidation catalysts", ACS Catal, 2, pp.647~666 (2012)
- Kelly SL, "Cytochrome P450: Structure, Mechanism, and Biochemistry", pp.2005, Kluwer Academic
- Moody SC, "CYP105 — diverse structures, functions and roles in an intriguing family of enzymes in Streptomyces", J. Appl. Microbiol, 117, pp.1549~1563 (2014)
- Taylor M, "Cytochrome P450105D1 (CYP105D1) from Streptomyces griseus:heterologous expression, activity, and activation effects of multiple xenobiotics", Biochem. Biophys. Res. Commun, 263, pp.838~842 (1999)
- Chun Y-J, "Electron transport pathway for a Streptomyces cytochrome P450: cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2)", J. Biol. Chem, 282, pp.17486~17500 (2007)
- Xu L-H, "Regio- and stereospecificity of filipin hydroxylation sites revealed by crystal structures of cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis", J. Biol. Chem, 285, pp.16844~16853 (2010)
- Takamatsu S, "Pentalenic acid is a shunt metabolite in the biosynthesis of the pentalenolactone family of metabolites:hydroxylation of 1-deoxypentalenic acid mediated by CYP105D7 (SAV_7469) of Streptomyces avermitilis", J. Antibiot, 64, pp.65~71 (2011)
- Xu L-H, "Structural basis for the 4’-hydroxylation of diclofenac by a microbial cytochrome P450 monooxygenase", Appl. Microbiol. Biotechnol, 99, pp.3081~3091 (2015)
- Liu L, "Hydroxylation of flavanones by cytochrome P450 105D7from Streptomyces avermitilis", J. Mol. Catal. B Enzym, 132, pp.91~97 (2016)
- Zhang J, "Conversion of fatty aldehydes into alk(a", e)nes by in vitro reconstituted cyanobacterial aldehyde-deformylating oxygenase with the cognate electron transfer system, 2013, pp.6, 1~
- Endo A, "ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum", J. Antibiot, 29, pp.1346~1348 (1976)
- Serizawa N., "Biochemical and molecular approaches for production of pravastatin, a potent cholesterol-lowering drug", Biotechnol. Annu. Rev, 2, pp.373~389 (1996)
- Matsuoka T, "Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus", Eur. J. Biochem, 184, pp.707~713 (1989)
- McLean KJ, "Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum", Proc. Natl. Acad. Sci. USA, 112, pp.2847~2852 (2015)
- Urlacher VB, "Cytochrome P450monooxygenases: an update on perspectives for synthetic application", Trends Biotechnol, 30, pp.26~36 (2012)
- Guengerich FP., "Rate-limiting steps in cytochrome P450 catalysis", Biol. Chem, 383, pp.1553~1564 (2002)
- Watanabe I, "Cloning, characterization and expression of the gene encoding cytochrome P-450sca-in2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor", Gene, 163, pp.81~85 (1995)
- Park J-W, "Bioconversion of compactin into pravastatin by Streptomyces sp", Biotechnol. Lett, 25, pp.1827~1831 (2003)
- Peng Y, "Bioconversion of compactin to pravastatin by Actinomadura sp. ATCC 55678", J. Mol. Catal. B Enzym, 10, pp.151~156 (2000)
- Chen C-H, "Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin", Curr. Microbiol, 53, pp.108~112 (2006)
- Fujii Y, "Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor", Biochem. Biophys. Res. Commun, 404, pp.511~516 (2011)
- Wester MR, "Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1Å resolution: evidence for an induced fit model of substrate binding", Biochemistry, 42, pp.9335~9345 (2003)
- Ba L, "Engineering of a hybrid biotransformation system for cytochrome P450sca-2in Escherichia coli", Biotechnol. J, 8, pp.785~793 (2013)
- Ba L, "Semi-rational engineering of cytochrome P450sca-2 in a hybrid system for enhanced catalytic activity: insights into the important role of electron transfer", Biotechnol. Bioeng, 110, pp.2815~2825 (2013)
- Pandey BP, "Regioselective hydroxylation of daidzein using P450(CYP105D7) from Streptomyces avermitilis MA4680", Biotechnol. Bioeng, 105, pp.697~704 (2010)
- Li S, "Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenase", Proc. Natl. Acad. Sci. USA, 106, pp.18463~18468 (2009)
- Zhang W, "New reactions and products resulting from alternative interactions between the P450 enzyme and redox partners", J. Am. Chem. Soc, 136, pp.3640~3646 (2014)
- Bernhardt R, "Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations", Appl. Microbiol. Biotechnol, 98, pp.6185~6203 (2014)